Anika Therapeutics, Inc. (ANIK) Operating cash flow 2016–2025
Anika Therapeutics, Inc. (ANIK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$11.2MFY2025 · since FY2016: $24.4M → $11.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.2M | +107.1% |
| FY2024 | $5.4M | +402.2% |
| FY2023 | -$1.8M | -140.6% |
| FY2022 | $4.4M | -47.5% |
| FY2021 | $8.4M | -35.7% |
| FY2020 | $13.1M | -64.7% |
| FY2019 | $37.0M | +6.0% |
| FY2018 | $34.9M | -14.4% |
| FY2017 | $40.8M | +66.9% |
| FY2016 | $24.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice